ArticleFrontiers in oncology2025
Oncofertility outcomes after fertility-sparing surgery in infertile BOT patients: results of a large retrospective study on controlled ovarian stimulation.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The optimal management of borderline ovarian tumors (BOTs), particularly the safety and efficacy of Methods: This retrospective observational study was conducted at the Reproductive Medical Center, Peking University Third Hospital (Beijing, China) and included 73 infertile BOT patients who underwent IVF between January 2008 and June 2022. Results: Median follow-up was 61.0 months (range: 7.0-156.0 months). The BOT recurrence rate was 20.5% (15/73), and the cumulative live birth rate per patient was 57.5% (42/73). There were no significant differences in the number of COS cycles ( Conclusion: In infertile BOT patients undergoing FSS, IVF significantly improves pregnancy outcomes. COS can be safely conducted post-FSS without increasing recurrence risk, provided initiation is delayed ≥3 months postoperatively and Gn administration is limited to ≤13 days.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.